Cisplatin-induced apoptosis in human promyelocytic leukemia cells

International Journal of Molecular Medicine

Volumn 18, Issue 3, 2006, Pages 511-516

  Previati, Maurizio ^a   Lanzoni, Irene ^a   Corbacella, Elisa ^a   Magosso, Sara ^a   Guaran, Valeria ^a   Martini, Alessandro ^a   Capitani, Silvano ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

Apoptosis; Cisplatin; HL 60; Nuclear fragmentation; Protein carbonylation; Reactive oxygen species

Indexed keywords

CISPLATIN; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL STRAIN HL 60; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECT; HUMAN; METABOLISM; PROMYELOCYTIC LEUKEMIA; PROTEIN CARBONYLATION;

APOPTOSIS; CELL CYCLE; CELL SURVIVAL; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; HL-60 CELLS; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALONDIALDEHYDE; PROTEIN CARBONYLATION; REACTIVE OXYGEN SPECIES;

EID: 33750584422     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.18.3.511     Document Type: Article

References (18)

1. Zanke BW, Boudreau K, Rubie E, Winnett E, Tibbles LA, Zon L, Kyriakis J, Liu FF and Woodgett JR: The stress-activated protein kinase pathway mediates cell death following injury induced by cis-platinum, UV irradiation or heat. Curr Biol 6: 606-613, 1996.
2. Chen Z, Seimiya H, Naito M, Mashima T, Kizaki A, Dan S, Imaizumi M, Ichijo H, Miyazono, K and Tsuruo T: ASK1 mediates apoptotic cell death induced by genotoxic stress. Oncogene 18: 173-180, 1999.
3. Fink D, Zheng H, Nebel S, et al: In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair. Cancer Res 15: 1841-1845, 1997.
4. Lanzi C, Perego P, Supino R, Romanelli S, Pensa T, Carenini N, Viano I, Colangelo D, Leone R, Apostoli P, Cassinelli G, Gambetta RA and Zunino F: Decreased drug accumulation and increased tolerance to DNA damage in tumor cells with a low level of cisplatin resistance. Biochem Pharmacol 15: 1247-1254, 1998.
5. Gabaizadeh R, Staecker H, Liu W and Van De Water TR: BDNF protection of auditory neurons from cisplatin involves changes in intracellular levels of both reactive oxygen species and glutathione. Mol Brain Res 50: 71-78, 1998. (Pubitemid 27488891)
6. Perez RP: Cellular and molecular determinants of cisplatin resistence. Eur J Cancer 34: 1535-1544, 1998.
7. Mase H, Sasaki A, Alcade RE, Nakayama S and Matsumura T: Regulation of apoptosis reduction in the cisplatin-resistent A431 cell line by Bcl-2 and CPP32. Chemotherapy 46: 67-76, 2000. (Pubitemid 30009336)
8. Majno G and Joris I: Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 46: 3-15, 1995.
9. Previati M, Lanzoni I, Corbacella E, et al: RNA expression induced by cisplatin in an organ of corti-derived immortalized cell line. Hear Res 196: 8-18, 2004.
10. Bertolaso L, Gibellini D, Secchiero P, et al: Accumulation of catalitically active PKC-ζ into the nucleus of HL50 cell line plays a key role in the induction of granulocyte differentiation mediated by all-trans retinoic acid. Br J Haematol 100: 541-549, 1998.
11. Smith PK, Krohn RI, Hermanson GT, et al: Measurement of protein using bicinchoninic acid. Anal Biochem 150: 76-85, 1985.
12. Levine RL, Williams JA, Stadtman ER and Shacter E: Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol 233: 346-357, 1994. (Pubitemid 24177560)
13. Berlett BS and Stadtman ER: Protein oxidation in aging, disease, and oxidative stress. J Biol Chem 272: 20313-20316, 1997.
14. Pascoe JM and Roberts JJ: Interactions between mammalian cell DNA and inorganic platinum compounds. I. DNA interstrand cross-linking and cytotoxic properties of platinum (II) compounds. Biochem Pharmacol 23: 1359-1365, 1974.
15. Kontos HA and Hess ML: Oxygen radicals and vascular damage. Adv Exp Med Biol 161: 365-375, 1983.
16. Dalle Donne I, Giustarini D, Colombo R, Rossi R and Milzani A: Protein carbonylation in human diseases. Trends Mol Med 9: 169-176, 2003.
17. Byoung JS, Yunjo S, Myung AB, Jae-Eun P, Jie W and Kyu- Shik J: Apoptosis of PC12 cells by 4-hydroxy-2-nonenal is mediated through selective activation of the c-Jun N-Terminal protein kinase pathway. Chem Biol Interact 130-132: 943-954, 2001.
18. Goto S, Yoshida K, Morikawa T, Urata Y, Suzuki K and Kondo T: Augmentation of transport for cisplatin-glutathione adduct in cisplatin-resistant cancer cells. Cancer Res 55: 4297-4301, 1995.